Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Advanced breast cancer | Women with advanced breast cancer |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of metastasis in skeleton | Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease | Baseline and after 6 months |
Not provided
Not provided
Inclusion Criteria:
- Cancer patient
Exclusion Criteria:
Not provided
Not provided
Women in Mid Norway living with advanced breast cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Beathe Sitter, PhD | Norwegian University of Science and Technology | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| D009362 | Neoplasm Metastasis |
| D004194 | Disease |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |
| D009385 | Neoplastic Processes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |